Top Medical News from Across Medscape

  • House Advances Broad Opioid Package; Senate Vote NextAlthough there was strong bipartisan support for the opioid package, lawmakers including a Texas physician already are looking for additional ways to combat abuse of drugs such as fentanyl.
  • FDA Approves Cemiplimab, First Drug for Advanced CSCCThe US Food and Drug Administration today approved cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced, unresectable CSCC.

Special Report

Business of Medicine

  • Should You Opt Out of Medicare? Pros and Cons Many physicians are fed up with Medicare's rules, reimbursement, and reporting requirements. But before letting your patient panel go, consider the possible benefits and risks.
  • 20 Wacky ICD-10 Codes for Thanksgiving The fall season brings a host of interesting and unusual ailments presenting themselves to physicians. Here's a list of less-common ICD-10 codes you might have to use in the coming months.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California